Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling

Journal of Neurochemistry

Volumn 110, Issue 2, 2009, Pages 707-718

  Katsuki, Hiroshi ^a   Kurimoto, Emi ^b   Takemori, Sachiko ^a   Kurauchi, Yuki ^a   Hisatsune, Akinori ^a   Isohama, Yoichiro ^a   Izumi, Yasuhiko ^b   Kume, Toshiaki ^b   Shudo, Koichi ^c   Akaike, Akinori ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Kawasaki   (Japan)

Author keywords

Lipopolysaccharide; Neuroinflammation; Neurotrophic factor; Parkinson disease; Substantia nigra; Tamibarotene

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HX 630; K 252A; MESSENGER RNA; RETINOIC ACID RECEPTOR; RETINOID; TAC 101; TAMIBAROTENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DRUG STRUCTURE; MALE; MESENCEPHALON; MICROGLIA; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ANIMALS; BENZOATES; BRAIN-DERIVED NEUROTROPHIC FACTOR; DOPAMINE; HUMANS; INFLAMMATION MEDIATORS; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEURONS; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, RETINOIC ACID; RETINOIDS; SIGNAL TRANSDUCTION; TETRAHYDRONAPHTHALENES;

MUS; RATTUS;

EID: 67649488308     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06171.x     Document Type: Article

References (40)

1. Arai H., Furuya T., Yasuda T., Miura M., Mizuno Y. Mochizuki H. (2004) Neurotoxic effects of lipopolysaccharide on nigral dopaminerguc neurons are mediated by microglial activation, interleukin-1β, and expression of caspase-11 in mice. J. Biol. Chem. 279, 51647 51653. (Pubitemid 40017915)
2. Bespalov M. M. Saarma M. (2007) GDNF family receptor complexes are emerging drug targets. Trends Pharmacol. Sci. 28, 68 74. (Pubitemid 46161837)
3. Block M., Zecca L. Hong J. (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57 69. (Pubitemid 46011999)
4. Borta A. Hoglinger G. U. (2007) Dopamine and adult neurogenesis. J. Neurochem. 100, 587 595. (Pubitemid 46095611)
5. Canon E., Cosgaya J. M., Scsucova S. Aranda A. (2004) Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells. Mol. Biol. Cell 15, 5583 5592. (Pubitemid 39564749)
6. Chen N. Napoli J. L. (2008) All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RARα. FASEB J. 22, 236 245.
7. Chen N., Onisko B. Napoli J. L. (2008) The nuclear transcription factor RARα associates with neuronal RNA granules and suppresses translation. J. Biol. Chem. 283, 20841 20847.
8. Dheen S. T., Jun Y., Yan Z., Tay S. S. W. Ling E. A. (2005) Retinoic and inhibits expression of TNF-α and iNOS in activated rat microglia. Glia 50, 21 31. (Pubitemid 40516817)
9. Fumagalli F., Racagni G. Riva M. A. (2006) Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease. Pharmacogenomics J. 6, 95 104.
10. Gofflot F., Chartoire N., Vasseur L., Heikkinen S., Dembele D., Le Merrer J. Auwerx J. (2007) Systematic gene expression mapping clusters nuclear receptors according to their function in the brain. Cell 131, 405 418. (Pubitemid 47576140)
11. Greer P. L. Greenberg M. E. (2008) From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59, 846 860.
12. Hanisch U.-K. Kettenmann H. (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387 1394. (Pubitemid 350014685)
13. Hu Y. Russek S. J. (2008) BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation. J. Neurochem. 105, 1 17.
14. Iravani M. M., Kashefi K., Mander P., Rose S. Jenner P. (2002) Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110, 49 58. (Pubitemid 34214759)
15. Jacobs S., Lie D. C., DeCicco K. L., Shi Y., DeLuca L. M., Gage F. H. Evans R. M. (2006) Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc. Natl Acad. Sci. USA 103, 3902 3907. (Pubitemid 43376653)
16. Kagechika H., Kawachi E., Hashimoto Y., Himi T. Shudo K. (1988) Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J. Med. Chem. 31, 2182 2192. (Pubitemid 18257985)
17. Kaplan D. R., Matsumoto K., Lucarelli E. Thiele C. J. (1993) Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron 11, 321 331. (Pubitemid 23250349)
18. Katsuki H., Okawara M., Shibata H., Kume T. Akaike A. (2006) Nitric oxide-producing microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain slice culture. J. Neurochem. 97, 1232 1242. (Pubitemid 43725564)
19. Kurauchi Y., Hisatsune A., Isohama Y. Katsuki H. (2009) Nitric oxide-cyclic GMP signaling pathway limits inflammatory degeneration of midbrain dopaminergic neurons: cell type-specific regulation of heme oxygenase-1 expression. Neuroscience 158, 856 866.
20. Lucarelli E., Kaplan D. R. Thiele C. J. (1995) Selective regulation of TrkA and TrkB receptors by retinoic acid and interferon-γ in human neuroblastoma cell lines. J. Biol. Chem. 270, 24725 24731.
21. Maden M. (2007) Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat. Rev. Neurosci. 8, 755 765. (Pubitemid 47462115)
22. Malaspina A. Michael-Titus A. T. (2008) Is the modulation of retinoid and retinoid-associated signaling a future therapeutic strategy in neurological trauma and neurodegeneration? J. Neurochem. 104, 584 595.
23. Masia S., Alvarez S., de Lera A. R. Barettino D. (2007) Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. Mol. Endocrinol. 21, 2391 2402. (Pubitemid 47529353)
24. McCaffery P., Zhang J. Crandall J. E. (2006) Retinoic acid signaling and function in the adult hippocampus. J. Neurobiol. 66, 780 791. (Pubitemid 43939199)
25. Mey J. (2006) New therapeutic target for CNS injury? The role of retinoic acid signaling after nerve lesions. J. Neurobiol. 66, 757 779. (Pubitemid 43939198)
26. Mingaud F., Mormede C., Etchamendy N. et al. (2008) Retinoid hyposignaling contributes to aging-related decline in hippocampal function in short-term/working memory organization and long-term delarative memory encoding in mice. J. Neurosci. 28, 279 291.
27. Ohnishi K. (2007) PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia. Int. J. Clin. Oncol. 12, 313 317. (Pubitemid 47573414)
28. Schrage K., Koopmans G., Joosten E. A. Mey J. (2006) Macrophages and neurons are targets of retinoic acid signaling after spinal cord contusion injury. Eur. J. Neurosci. 23, 285 295.
29. Segal R. A. (2003) Selectivity in neurotrophin signaling: theme and variations. Annu. Rev. Neurosci. 26, 299 330. (Pubitemid 37064936)
30. Shibata H., Katsuki H., Nishiwaki M., Kume T., Kaneko S. Akaike A. (2003) Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures: role of inducible nitric oxide synthase and protection by indomethacin. J. Neurochem. 86, 1201 1212. (Pubitemid 37022196)
31. Sun S. Y., Yue P., Dawson M. I. et al. (1997) Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res. 57, 4931 4939. (Pubitemid 27469005)
32. Tansey M. G., McCoy M. K. Frank-Cannon T. C. (2007) Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp. Neurol. 208, 1 25. (Pubitemid 47603240)
33. Thang S. H., Kobayashi M. Matsuoka I. (2000) Regulation of glial cell line-derived neurotrophic factor responsiveness in developing rat sympathetic neurons by retinoic acid and bone morphogenetic protein-2. J. Neurosci. 20, 2917 2925. (Pubitemid 30220317)
34. Umemiya H., Fukasawa H., Ebisawa M. et al. (1997a) Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. J. Med. Chem. 40, 4222 4234. (Pubitemid 28042303)
35. Umemiya H., Kagechika H., Fukasawa H. et al. (1997b) Action mechanism of retinoid-synergistic dibenzodiazepines. Biochem. Biophys. Res. Commun. 233, 121 125. (Pubitemid 27215921)
36. Wang T., Niwa S., Bouda K., Matsuura S., Homma T., Shudo K. Nagai H. (2000) The effect of Am-80, one of retinoids derivatives on experimental allergic encephalomyelitis in rats. Life Sci. 67, 1869 1879.
37. Whitton P. S. (2007) Inflammation as a causative factor in the aetiology of Parkinson's disease. Br. J. Pharmacol. 150, 963 976. (Pubitemid 46628616)
38. Xu J. Drew P. D. (2006) 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J. Neuroimmunol. 171, 135 144. (Pubitemid 41832284)
39. Yamakawa T., Kagechika H., Kawachi E., Hashimoto Y. Shudo K. (1990) Retinobenzoic acids. 5. Retinoidal activities of compounds having a trimethylsilyl or trimethylgermyl group(s) in human promyelocytic leukemia cells HL-60. J. Med. Chem. 33, 1430 1437. (Pubitemid 20148381)
40. Zetterstrom R. H., Lindqvist E., Mata de Urquiza A., Tomac A., Eriksson U., Perlmann T. Olson L. (1999) Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur. J. Neurosci. 11, 407 416. (Pubitemid 29050442)